Avadel

This study tested a new once-nightly medication (FT218) for people with narcolepsy who experience excessive daytime sleepiness and sudden muscle weakness (cataplexy). It included 184 participants who either switched from a twice-nightly medication or were new to this type of trea…

This study tested a new once-nightly medication called FT218 in 157 people with idiopathic hypersomnia, a condition causing severe daytime sleepiness despite long sleep. The goal was to see if FT218 improves wakefulness and reduces symptoms compared to a placebo. Participants cou…

This study followed 71 adults with narcolepsy who were prescribed LUMRYZ by their own doctors. Over 4 months, participants filled out questionnaires about their sleepiness, symptoms, and quality of life. The goal was to see how well the drug works in real-world settings, not in a…